Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy

Whole-brain network connectivity has been shown to be a useful biomarker of cerebral amyloid angiopathy and related cognitive impairment. We evaluated an automated DTI-based method, peak width of skeletonized mean diffusivity, in cerebral amyloid angiopathy, together with its association with conven...

Full description

Saved in:
Bibliographic Details
Published in:American journal of neuroradiology : AJNR 2021-05, Vol.42 (5), p.875-881
Main Authors: Raposo, N, Zanon Zotin, M C, Schoemaker, D, Xiong, L, Fotiadis, P, Charidimou, A, Pasi, M, Boulouis, G, Schwab, K, Schirmer, M D, Etherton, M R, Gurol, M E, Greenberg, S M, Duering, M, Viswanathan, A
Format: Article
Language:English
Subjects:
Adult Brain
Aged
Aged, 80 and over
Biomarkers
Cerebral Amyloid Angiopathy - diagnostic imaging
Cerebral Amyloid Angiopathy - psychology
Cerebral Small Vessel Diseases - diagnostic imaging
Cognition
Cognitive Dysfunction - diagnostic imaging
Cognitive Dysfunction - psychology
Diffusion Magnetic Resonance Imaging
Diffusion Tensor Imaging - methods
Female
Functional
Human health and pathology
Humans
Image Processing, Computer-Assisted - methods
Life Sciences
Male
Neuroimaging
Psychomotor Performance
Reaction Time
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Whole-brain network connectivity has been shown to be a useful biomarker of cerebral amyloid angiopathy and related cognitive impairment. We evaluated an automated DTI-based method, peak width of skeletonized mean diffusivity, in cerebral amyloid angiopathy, together with its association with conventional MRI markers and cognitive functions. We included 24 subjects (mean age, 74.7 [SD, 6.0] years) with probable cerebral amyloid angiopathy and mild cognitive impairment and 62 patients with MCI not attributable to cerebral amyloid angiopathy (non-cerebral amyloid angiopathy-mild cognitive impairment). We compared peak width of skeletonized mean diffusivity between subjects with cerebral amyloid angiopathy-mild cognitive impairment and non-cerebral amyloid angiopathy-mild cognitive impairment and explored its associations with cognitive functions and conventional markers of cerebral small-vessel disease, using linear regression models. Subjects with Cerebral amyloid angiopathy-mild cognitive impairment showed increased peak width of skeletonized mean diffusivity in comparison to those with non-cerebral amyloid angiopathy-mild cognitive impairment ( < .001). Peak width of skeletonized mean diffusivity values were correlated with the volume of white matter hyperintensities in both groups. Higher peak width of skeletonized mean diffusivity was associated with worse performance in processing speed among patients with cerebral amyloid angiopathy, after adjusting for other MRI markers of cerebral small vessel disease. The peak width of skeletonized mean diffusivity did not correlate with cognitive functions among those with non-cerebral amyloid angiopathy-mild cognitive impairment. Peak width of skeletonized mean diffusivity is altered in cerebral amyloid angiopathy and is associated with performance in processing speed. This DTI-based method may reflect the degree of white matter structural disruption in cerebral amyloid angiopathy and could be a useful biomarker for cognition in this population.
ISSN:0195-6108
1936-959X
DOI:10.3174/AJNR.A7042